Building business partnerships in human and animal health

Parties with an interest to tackle major challenges related to infectious diseases in both humans and animals, in collaboration with appropriate business partners, turn to Immuno Valley. We effectively match business and science to specifically build, nurture, and support lasting business partnerships for R&D. Read more about How We Work>

Contact us

Interested in Immuno Valley Network or Services? 
Call us: +31 (0) 30 253 1142
Send an email: info@immunovalley.nl

 

LATEST NEWS

  1. ALTANT ASIA thesis defence: Chicken CATH-2 possible alternative to antibiotics

    While antibiotics have effectively been used for the treatment of bacterial infections in humans and animals, many bacteria have developed antibiotic resistance. New anti-infective therapies need to be developed, cathelicidins are interesting candidates for the development of novel antibiotics. Maarten Coorens writes about chicken cathelicidin-2 as a strong candidate, in his PhD thesis. The research was supported by the Immuno Valley ALTANT ASIA 2 program of the Dutch Ministry of Economic Affairs. Read more...

  2. € 28 million European subsidy for PERISCOPE project

    The international PERISCOPE project has been granted a € 28 million European IMI 2 subsidy - of which € 7 million from the Bill and Melinda Gates Foundation- in order to better map the immune response to pertussis infection and vaccination. Read more...

  3. Dutch Minister of Health invests millions in new antibiotics and alternatives

    The Dutch Minister of Health, Welfare and Sport, Edith Schippers, will invest more than 6 million euros in research into new antibiotics during the next four years. The money is intended for a new research programme for the development of antibiotics and is associated with the new National Antibiotic Development Platform. The platform will be part of the Netherlands Centre for One Health and will consolidate and strengthen research. Both the platform and the research programme will start before the end of this year. Schippers announced this September 21th, 2016 in New York, where she spoke about the need to control antibiotic resistance at a special meeting of the General Assembly of the United Nations. Read more...

More news

UPCOMING EVENTS

  1. Innovation Days

    Innovation Days brings together public and private actors of the life sciences to maximize business opportunities during two days of high level conferences and one-on-one partnering meetings.

  2. Drug Development Course

    This mini-course on drug development provides an overview of the now-a-days drug development process.

  3. 5th Beneficial Microbes Conference

    The 5th Beneficial Microbes Conference will focus on pre- and probiotics for lifelong human and animal health and will inform you on the latest scientific results and future developments from a new perspective, that is, the impact of pre- and probiotics related to the specific needs of human and animal growth and development.

  4. World Vaccine Congress 2016

    The World Vaccine Congress is the place where the global vaccine industry meet to discuss commercial and scientific issues around regulation, strategy, manufacturing and clinical trials, as well as respiratory, cancer, and emerging diseases. It will be organised from 10-12 October 2016 in Barcelona Spain, offering you multiple streams to make the most of your attendance by building a conference agenda that will perfectly answer your day-to-day challenges.

Partners